Clinical Trial Update: CONcomitant eValuation of Epicor Left atRial Therapy for AF [NA]

View source ↗

Summary

A trial evaluating Epicor Left Atrial Therapy for atrial fibrillation sponsored by Abbott Medical Devices was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Epicor Left Atrial Therapy

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation | NA | Status: TERMINATED | Results posted: 2014-05-05